InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Meta Platforms acquisition of Manus AI
We advised Meta on the transaction
Shenzhen Xunce Technology HK$1.08 billion IPO
We advised Xunce on its IPO and HKEX listing
SI Group comprehensive recapitalization
We advised the administrative agent and a revolving lender on the recapitalization
Urban One capital raise and refinancing transaction
We advised an ad hoc group of noteholders on the transaction
Bloom Energy $600 million secured revolving credit facility
We advised the lead arrangers, administrative agent and lender on the facility
Trial victory for Magnolia Medical in patent infringement litigation
We secured a unanimous jury verdict against Magnolia’s sole competitor in the market for initial specimen diversion devices
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares
Azul confirms chapter 11 plan of reorganization
We are advising Azul in connection with its chapter 11 restructuring
DTE Energy $1.5 billion at-the-market offering
We advised the forward counterparties on the offering